首页|心脏衰老与线粒体治疗

心脏衰老与线粒体治疗

扫码查看
随人口老龄化进程加速,由心脏衰老引发的各类心血管疾病已成为不可忽略的健康问题.心脏中,约95%的ATP来源于心肌线粒体,以维持心脏泵血功能.线粒体功能障碍可导致心肌能量不足,心肌细胞受损死亡或心肌衰老.因此,线粒体的功能完好对于维持心脏正常功能具有重要作用,并被认为是心脏衰老的一个关键特征.本文对心脏衰老与线粒体功能障碍进行综述,主要概述了衰老心脏的特征,衰老心肌细胞线粒体结构与功能的变化,重点阐述线粒体功能障碍导致心脏衰老的5大因素,包括线粒体形态数量的改变,线粒体DNA突变,线粒体质量控制失败,线粒体酶的改变,线粒体相关代谢产物及应激信号的变化.总结了靶向线粒体的心脏衰老治疗方式及作用机制,同时探讨了靶向年龄相关的线粒体治疗心脏衰老的现状和未来方向.
Mitochondrial Therapy in Cardiac Aging
With the acceleration of population aging,all kinds of cardiovascular diseases caused by car-diac aging have become a health problem that cannot be ignored.In the heart,about 95%of ATP come from the cardiomyocytes to maintain the pumping function.Mitochondrial dysfunction can lead to myocar-dial energy deficiency,cardiomyocytes damage and death,or myocardial senescence.Therefore,the in-tact function of mitochondria plays an important role in maintaining the normal function of the heart and is considered as a key feature of cardiac aging.This paper reviews cardiac aging and mitochondrial dysfunc-tion,and mainly summarizes the characteristics of aging heart and the changes in mitochondrial structure and function of senescent cardiomyocytes.We focus on the five major factors leading to cardiac aging caused by mitochondrial dysfunction,including changes in the mitochondrial numbers and morphology,mitochondrial DNA mutations,mitochondrial quality control failures,mitochondrial enzyme changes,and mitochondria-related metabolites and stress signals changes.We also summarize the treatment methods and mechanism of cardiac aging by targeting mitochondria,and discuss the current status and future di-rection of mitochondrial therapy for cardiac aging.

cardiac agingmitochondrial dysfunctionmitochondrial transplantation

靳宁、刘岳思颖、解军

展开 >

山西医科大学山西省出生缺陷与细胞再生重点实验室,煤炭环境致病性与防治教育部重点实验室,太原 030001

心脏衰老 线粒体功能障碍 线粒体移植

中央引导地方科技发展专项山西省青年基金山西省省级大学生创新创业训练计划

YDZJSX2021B00820210302122324320230330

2024

中国生物化学与分子生物学报
中国生物化学与分子生物学会 北京大学

中国生物化学与分子生物学报

CSTPCD北大核心
影响因子:0.617
ISSN:1007-7626
年,卷(期):2024.40(5)
  • 130